Imaging response predictors following drug eluting beads chemoembolization in the neoadjuvant liver transplant treatment of hepatocellular carcinoma

doi:10.4254/wjh.v12.i1.21

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6655)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-7) series.

Item

Count

PDF

419

WORD

215

HTML

3340

Figures (1-6)

245

Tables (1-7)

299

Sum=4518

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

649

Download

1488

Sum=2137

Jan 27, 2020 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Hepatol. Jan 27, 2020; 12(1): 21-33
Published online Jan 27, 2020. doi: 10.4254/wjh.v12.i1.21

Full Size Figure Download Figure

Figure 4 Flowchart of the patients included in the study. HCC: Hepatocellular carcinoma; CT: Computed tomography; MRI: Magnetic resonance imaging; DEB-TACE: Drug-eluting bead transarterial chemoembolization.

Citation: Galastri FL, Nasser F, Affonso BB, Valle LGM, Odísio BC, Motta-Leal Filho JM, Salvalaggio PR, Garcia RG, de Almeida MD, Baroni RH, Wolosker N. Imaging response predictors following drug eluting beads chemoembolization in the neoadjuvant liver transplant treatment of hepatocellular carcinoma. World J Hepatol 2020; 12(1): 21-33
URL: https://www.wjgnet.com/1948-5182/full/v12/i1/21.htm
DOI: https://dx.doi.org/10.4254/wjh.v12.i1.21